SARS-CoV-2 antibody response duration and neutralization following natural infection

• Published in: Journal of clinical virology plus 2023-08, Vol.3 (3), p.100158, Article 100158
• Main Authors: Dukes, Christopher W, Rossetti, Renata AM, Hensel, Jonathan A, Snedal, Sebastian, Cubitt, Christopher L, Schell, Michael J, Abrahamsen, Martha, Isaacs-Soriano, Kimberly, Kennedy, Kayoko, Mangual, Leslie N, Whiting, Junmin, Martinez-Brockhus, Veronica, Islam, Jessica Y, Rathwell, Julie, Beatty, Matthew, Hall, Amy M, Abate-Daga, Daniel, Giuliano, Anna R, Pilon-Thomas, Shari
• Format: Article
• Language: English
• Subjects: COVID-19; Neutralizing antibodies; SARS-CoV-2; Serosurvey
• ISSN: 2667-0380; 2667-0380
• DOI: 10.1016/j.jcvp.2023.100158

•83.2% of COVID-19 convalescent participants positive for neutralizing antibodies.•Positive association of neutralization capacity with higher antibody levels.•Older participants had higher antibody levels and neutralization capacity.•Ethnicity, heart, and autoimmune disease associated with increased antibody levels.•Antibody levels drop for unvaccinated participants at 3-month follow-up. The role of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) neutralizing antibody response from natural infection and vaccination, and the potential determinants of this response are poorly understood. Characterizing this antibody response and the factors associated with neutralization can help inform future prevention efforts and improve clinical outcomes in those infected. The goals of this study were to prospectively evaluate SARS-CoV-2 antibody levels and the neutralizing antibody responses among naturally infected adults and to determine demographic and behavioral factors independently associated with these responses. Serum was collected from seropositive individuals at baseline, four-weeks, and three-months following their first study visit to be evaluated for antibody levels. Detection of neutralizing antibodies was performed at baseline. Participant demographic and behavioral information was collected via web questionnaire prior to their first visit. At baseline, higher antibody levels were associated with better neutralization capacity, with 83% of participants having detectable neutralizing antibodies. We found an age-dependent effect on antibody level and neutralization capacity with participants over 65 years having significantly higher levels. Ethnicity, heart disease, autoimmune disease, and COVID symptoms were associated with higher antibody levels, but not with increased neutralization capacity. Work environment during the pandemic correlated with increased neutralization capacity, while kidney or liver disease and traveling out of state after February 2020 correlated with decreased neutralization capacity, however neither correlated with antibody levels. Our data show that natural infection by SARS-CoV-2 can induce a humoral response reflected by high antibody levels and neutralization capacity.